SJF Ventures

SJF Ventures Research

Investment Thesis

SJF Ventures is a mission-driven venture capital firm that backs high-growth companies creating a healthier, smarter, and cleaner future. Across the firm’s site, its thesis is consistent: invest in companies that combine strong commercial upside with measurable environmental and social impact. The current impact framework emphasizes six interconnected areas: clean energy and electrification; supply chain and circular economy; sustainability and climate resilience; education and employment; health and wellness; and government and civil society. That makes SJF a cross-sector impact fund rather than a single-theme specialist, but the portfolio still has a clear pattern: practical software and technology that changes how critical systems operate.

The firm’s public materials also show a bias toward durable operating value rather than hype. SJF repeatedly describes itself as partnering with “visionary entrepreneurial teams” and stresses extraordinary results, lasting positive change, and board-level engagement. The portfolio reflects that posture. Recent investments and portfolio coverage center on health outcomes, climate/electrification, nuclear operations, supply chain resilience, government workflow automation, and logistics software. The connective tissue is not a single product category; it is a preference for software-enabled operational leverage in large, messy, real-world systems.

Stage Focus

SJF appears to invest primarily in growth-oriented rounds, while still showing enough range to participate in earlier-stage companies when the thesis is strong. The clearest current fund-level disclosure says the firm invests between $3 million and $15 million, and the team page emphasizes a long record of board-level involvement across more than 90 ventures. Public announcements on the site in 2025 and 2026 include Series A, Series B, Series C, and Series E activity, which suggests the firm is comfortable moving with companies after an initial product or market signal is visible.

A concise way to describe the stage posture is: growth-capital oriented, with meaningful participation from Series A through Series C and occasional earlier conviction bets. SJF does not read like a pre-seed-only fund, and it is not confined to late-stage crossover investing either. It sits in the middle of the market where operational depth, impact measurement, and a credible scaling path all matter.

Check Size

The most explicit current source-backed range on the site is $3 million to $15 million per investment. That is consistent with the fund-level positioning and with the way the firm describes its role in company building. This is a meaningful check size that fits lead or co-lead behavior in growth rounds and also allows the firm to support follow-on financing when a portfolio company needs more capital to scale.

Lead Tendency

SJF leans toward leading or co-leading rounds, especially where the company fits the firm’s sector thesis and the team is committed to hands-on partnership. Recent portfolio posts on the site include titles such as “SJF Leads NewEdge Power’s Series A” and several other financing announcements where SJF is clearly part of the core capital syndicate. The firm also describes its team as deeply engaged at the board level, which is consistent with a lead-oriented posture rather than passive participation.

Recent Activity

The firm has been visibly active through 2025 and 2026. Recent site posts include investments and thesis pieces across climate, health, nuclear, and supply chain.

• In July 2026, SJF published a DUOS case study on early AI adoption and improved Medicare member outcomes.
• In May 2026, the firm highlighted a claims study showing digital health performance, reinforcing its healthcare platform interest.
• In April 2026, SJF published “Investing in Maternal Health,” showing continued attention to maternal outcomes and digital care infrastructure.
• In March 2026, it published “Why We Invested in Azra AI,” centered on oncology workflow and patient routing.
• In February 2026, SJF published a nuclear AI thesis piece and a separate note on Zero Homes.
• In September 2025, SJF highlighted Nuclearn and later announced Lōvu Health’s Series A.
• In August 2025, the firm led NewEdge Power’s Series A.
• In May 2025, it announced new funding for Tradeverifyd.
• In April 2025, it participated in additional funding for Respondology and covered Authorium’s new capital and product launch.
• In March and January 2025, it covered major portfolio financings for Terabase and Tive.

The pace of publishing and financing suggests an actively deploying platform rather than a dormant legacy fund.

Portfolio Highlights

SJF’s portfolio spans climate, supply chain, health, education, and operational software. A few representative companies stand out:

• Nextracker, one of the firm’s best-known exits, later completed an IPO after an acquisition path.
• Vital Farms, another notable exit, became a public company and remains a strong example of impact-oriented consumer and food investing.
• Waycare was acquired by Rekor Systems.
• Binti is a major child-welfare software platform serving hundreds of agencies.
• Zero Homes is focused on home electrification and contractor workflow.
• Azra AI supports oncology care teams and cancer patient navigation.
• Nuclearn applies AI to nuclear operations and regulatory work.
• NewEdge Power targets utility-scale battery storage and solar development.
• Tradeverifyd addresses supply-chain risk and compliance.
• Respondology automates comment moderation and social media safety.
• Authorium modernizes government procurement workflows.
• Terabase digitalizes utility-scale solar deployment.
• Tive provides real-time shipment visibility.
• Solera Health connects people to preventive and chronic-care programs.
• Iron Sheepdog improves short-haul trucking workflows and material movement.

Team

• Dave Kirkpatrick, Managing Director and co-founder, focuses on high-growth positive impact ventures and helped capitalize five funds totaling $435 million.
• Alan Kelley, Managing Director, focuses on clean energy, software, and sustainable products.
• Arrun Kapoor, Managing Director for the New York City office, brings experience in education, health, and portfolio board work.
• Perry Clarkson, Managing Director in New York, brings life sciences and healthcare investing experience.
• David Griest, Managing Director in Seattle, leads supply chain, circular economy, food/tech, and tech-enabled services investing.
• Cody Nystrom, Managing Director, leads the health and wellness practice.
• Joey Barrick, Principal in North Carolina, adds industrial and energy-adjacent operating and finance experience.

The team composition supports the firm’s cross-sector model: different partners own different thematic lanes, but the overall posture is coordinated and board-engaged.

Decision Process

SJF’s decision process looks partnership-driven and thesis-led. The public language emphasizes collaboration with entrepreneurs, time-tested perspective, and established networks. The firm’s board-level posture suggests that it expects a serious working relationship rather than a purely transactional capital relationship. That usually implies multi-partner consensus, strong reference checking, and a focus on whether the company’s operating problem is large enough for SJF to add real value.

Founder Preferences

SJF appears to prefer founders who are mission-aligned, operationally credible, and willing to build in complex sectors. The firm repeatedly backs teams working on real infrastructure problems: healthcare navigation, climate and electrification, supply-chain integrity, government workflow, and industrial automation. The implied founder profile is a team that understands the operational pain firsthand, can build software into difficult workflows, and wants active strategic help from investors.

Geographic Focus

SJF is a U.S.-anchored firm with offices in Durham, New York, San Francisco, and Seattle. Its portfolio and public examples are nationwide, and its impact strategy reads as sector-led rather than region-constrained. The most accurate shorthand is U.S.-wide with multi-office coverage, not a narrow coastal-only focus.